pirenzepine has been researched along with Psychoses, Drug in 19 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olanzapine has been shown to be very effective in these situations and its use is suggested as first-choice therapy." | 2.70 | Ecstasy-induced psychotic disorder: six-month follow-up study. ( Calle, R; Gutiérrez-Fraile, M; Iraurgi, I; Jiménez-Lerma, JM; Landabaso, MA; Sanz, J, 2002) |
| "The psychotic symptoms associated with Parkinson's disease can be as varied as the motor symptoms." | 2.40 | Management of psychotic aspects of Parkinson's disease. ( Juncos, JL, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breier, A | 1 |
| Sutton, VK | 1 |
| Feldman, PD | 1 |
| Kadam, DL | 1 |
| Ferchland, I | 1 |
| Wright, P | 1 |
| Friedman, JH | 1 |
| Gupta, N | 1 |
| Malhotra, P | 1 |
| Tamam, L | 1 |
| Yerdelen, D | 1 |
| Ozpoyraz, N | 1 |
| Friedman, J | 1 |
| Alao, AO | 1 |
| Yolles, JC | 1 |
| Passik, SD | 1 |
| Cooper, M | 1 |
| Juncos, JL | 1 |
| Berk, M | 1 |
| Brook, S | 1 |
| Trandafir, AI | 1 |
| Benazzi, F | 2 |
| Molho, ES | 1 |
| Factor, SA | 1 |
| Weiner, WJ | 1 |
| Minagar, A | 1 |
| Shulman, LM | 1 |
| Misra, LK | 1 |
| Kofoed, L | 1 |
| Oesterheld, JR | 1 |
| Richards, GA | 1 |
| Fahy, S | 1 |
| Fahy, TJ | 1 |
| Fernandez, HH | 1 |
| Llorca, PM | 1 |
| Vaiva, G | 1 |
| Lancon, C | 1 |
| Aldurra, G | 1 |
| Crayton, JW | 1 |
| Chacón, JR | 1 |
| Durán, E | 1 |
| Durán, JA | 1 |
| Alvarez, M | 1 |
| Landabaso, MA | 1 |
| Iraurgi, I | 1 |
| Jiménez-Lerma, JM | 1 |
| Calle, R | 1 |
| Sanz, J | 1 |
| Gutiérrez-Fraile, M | 1 |
1 review available for pirenzepine and Psychoses, Drug
| Article | Year |
|---|---|
Management of psychotic aspects of Parkinson's disease.
Topics: Algorithms; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; C | 1999 |
4 trials available for pirenzepine and Psychoses, Drug
| Article | Year |
|---|---|
Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dopamine Agents; Female; Humans; Male; Olanzapine; Park | 2002 |
A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cannabis; Double-Blind Method; Dyskinesia, Drug-Induce | 1999 |
[Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Female; Humans | 2002 |
Ecstasy-induced psychotic disorder: six-month follow-up study.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Hallucinogens; | 2002 |
14 other studies available for pirenzepine and Psychoses, Drug
| Article | Year |
|---|---|
Olanzapine: a proarrhythmic drug?
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbidopa; Electrocardiography; F | 2002 |
Psychosis associated with interferon alfa therapy for chronic hepatitis B.
Topics: Adult; Antipsychotic Agents; Antiviral Agents; Benzodiazepines; Hepatitis B, Chronic; Humans; Interf | 2003 |
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dopamine Agonists; Female; Humans; M | 1998 |
Isoniazid-induced psychosis.
Topics: Adult; Antipsychotic Agents; Antitubercular Agents; Benzodiazepines; Female; Humans; Isoniazid; Olan | 1998 |
Complicated delirium in a cancer patient successfully treated with olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Lymphoma, Non-Hodgkin; Middle Ag | 1999 |
Olanzapine-induced psychotic mania in bipolar schizoaffective disorder.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; Humans; Middle Aged; Olanzapine; Pi | 1999 |
Worsening of motor features of parkinsonism with olanzapine.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Female; Humans | 1999 |
Olanzapine-induced psychotic mania in bipolar schizo-affective disorder.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; Humans; Middle Aged; Olanzapine; Pi | 1999 |
Quetiapine for l-dopa-induced psychosis in PD.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Levodopa | 2000 |
Olanzapine treatment of methamphetamine psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Humans; Male; Metha | 2000 |
Induction of manic symptoms by novel antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Female; Humans; Middle Aged; Olanzapine; Pirenzepine; Psychos | 2000 |
Quetiapine for l-dopa-induced psychosis in PD.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Levodopa; Parkinson Disease; Pirenzepine; Psychose | 2000 |
Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Ps | 2001 |
Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report.
Topics: Adolescent; Benzodiazepines; Drug Therapy, Combination; Fluoxetine; Hallucinogens; Humans; Lysergic | 2001 |